ÂÜÀòÂÒÂ×

The Leadership Team at Carbon Biosciences drives the strategic vision and operational execution of the company's innovative gene therapy initiatives. Comprising experts in nonclinical development, manufacturing, and platform development, this team collaborates to advance the proprietary parvovirus platform, ensuring alignment with clinical goals, streamlining processes, and fostering partnerships to address challenging diseases. Their collective expertise shapes the direction of research, development, and commercialization efforts, positioning Carbon Biosciences at the forefront of gene therapy advancements.